Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Folini

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Pediatric Pulmonology|May 12, 2017
CPAM type 2-derived mesenchymal stem cells: Malignancy risk study in a 14-month-old boyGloria Pelizzo, Maria A Avanzini, Marco Folini, et al.
Cancer Research|February 27, 2009
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase CepsilonPaolo Gandellini, Marco Folini, Nicole Longoni, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 17, 2017
Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on TubuvalineMonica Sani, Paolo Lazzari, Marco Folini, et al.
Molecular Cancer|January 23, 2010
miR-21: an oncomir on strike in prostate cancerMarco Folini, Paolo Gandellini, Nicole Longoni, et al.
Oncogene|January 16, 2004
Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cellsMarzia Pennati, Mara Binda, Gennaro Colella, et al.
Current Pharmaceutical Biotechnology|February 22, 2008
Photochemical internalization: a new tool for drug deliveryKristian Berg, Marco Folini, Lina Prasmickaite, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancerAlessia Lopergolo, Valentina Nicolini, Enrica Favini, et al.
Nucleic Acids Research|February 13, 2025
The G-quadruplex experimental drug QN-302 impairs liposarcoma cell growth by inhibiting MDM2 expression and restoring p53 levelsBeatrice Tosoni, Eisa Naghshineh, Irene Zanin, et al.
Journal of Translational Medicine|May 22, 2026
FASN for diffuse malignant peritoneal mesothelioma: a prognostic biomarker after CRS+HIPEC and a therapeutic targetValentina Doldi, Chiara Maura Ciniselli, Claudia Aurelio, et al.
Nucleic Acids Research|February 19, 2025
The G-quadruplex experimental drug QN-302 impairs liposarcoma cell growth by inhibiting MDM2 expression and restoring p53 levelsBeatrice Tosoni, Eisa Naghshineh, Irene Zanin, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Pediatric Pulmonology|May 12, 2017
CPAM type 2-derived mesenchymal stem cells: Malignancy risk study in a 14-month-old boyGloria Pelizzo, Maria A Avanzini, Marco Folini, et al.
Cancer Research|February 27, 2009
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase CepsilonPaolo Gandellini, Marco Folini, Nicole Longoni, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 17, 2017
Synthesis and Superpotent Anticancer Activity of Tubulysins Carrying Non-hydrolysable N-Substituents on TubuvalineMonica Sani, Paolo Lazzari, Marco Folini, et al.
Molecular Cancer|January 23, 2010
miR-21: an oncomir on strike in prostate cancerMarco Folini, Paolo Gandellini, Nicole Longoni, et al.
Oncogene|January 16, 2004
Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cellsMarzia Pennati, Mara Binda, Gennaro Colella, et al.
Current Pharmaceutical Biotechnology|February 22, 2008
Photochemical internalization: a new tool for drug deliveryKristian Berg, Marco Folini, Lina Prasmickaite, et al.
The Journal of Clinical Endocrinology and Metabolism|November 27, 2013
Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancerAlessia Lopergolo, Valentina Nicolini, Enrica Favini, et al.
Nucleic Acids Research|February 13, 2025
The G-quadruplex experimental drug QN-302 impairs liposarcoma cell growth by inhibiting MDM2 expression and restoring p53 levelsBeatrice Tosoni, Eisa Naghshineh, Irene Zanin, et al.
Journal of Translational Medicine|May 22, 2026
FASN for diffuse malignant peritoneal mesothelioma: a prognostic biomarker after CRS+HIPEC and a therapeutic targetValentina Doldi, Chiara Maura Ciniselli, Claudia Aurelio, et al.
Nucleic Acids Research|February 19, 2025
The G-quadruplex experimental drug QN-302 impairs liposarcoma cell growth by inhibiting MDM2 expression and restoring p53 levelsBeatrice Tosoni, Eisa Naghshineh, Irene Zanin, et al.
Pageof 7